Medicus Pharma Ltd. Common Stock (MDCX)
CA — Healthcare Sector
Automate Your Wheel Strategy on MDCX
With Tiblio's Option Bot, you can configure your own wheel strategy including MDCX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol MDCX
- Rev/Share 0.0
- Book/Share 0.2274
- PB 10.1129
- Debt/Equity 1.5287
- CurrentRatio 1.287
- ROIC -2.0084
- MktCap 49349150.0
- FreeCF/Share -1.1023
- PFCF -3.1343
- PE -1.9897
- Debt/Assets 0.4161
- DivYield 0
- ROE -5.4935
- Rating C-
- Score 1
- Recommendation Strong Sell
- P/E Score 1
- DCF Score 3
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
MDCX
Published: February 11, 2025 by: Newsfile Corp
Sentiment: Neutral
Published: February 11, 2025 by: Newsfile Corp
Sentiment: Neutral
Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital Market Toronto, Ontario and Philadelphia, Pennsylvania--(Newsfile Corp. - February 11, 2025) - Medicus Pharma Ltd.
Read More
Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
MDCX
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital Market Medicus Pharma Ltd.'s shares will remain listed on the NASDAQ Capital Market
Read More
About Medicus Pharma Ltd. Common Stock (MDCX)
- IPO Date 2024-11-15
- Website https://medicuspharma.com
- Industry Biotechnology
- CEO Raza Bokhari MBA
- Employees 12
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.